Core Team
Georg Avakyan
CEO and Co-Founder
As he delved into pharmaceutical studies during his studies at ETH Zurich, Georg quickly recognized that clinical trials represented a significant bottleneck, often slowing the market-access of new pharmaceutical products. This realization brought him to action, leading to a firm commitment to tackle this issue head-on. As our CEO, Georg steers our platform with a patient-centered approach, aiming to streamline the clinical trial process. His vision is clear: to enhance the efficiency of trials, thus accelerating the arrival of new treatments to the market, and ultimately, to the patients who need them most.
Anastasija Kikase
COO and Co-Founder
During her time at a clinical supply company, Anastasia frequently heard from industry partners about a significant problem: it was too hard to find the right clinical trials for patients. This challenge sparked an idea. With a deep commitment to making things better, Anastasia set out to create a solution that would make it easier to connect patients with the trials they need. Her dedication to this goal is the foundation of our platform, which aims to make clinical trials more accessible and speed up medical progress.
Adrian Bertagnoli
CTO and Co-Founder
Adrian, our Chief Technology Officer, is the technical maestro behind our platform's architecture. With a BEng in Biomedical Engineering from King's College London and an MSc in Biomedical Engineering from ETH, his academic foundation is as robust as it is relevant. His hands-on experience as a graduate researcher at MIT has sharpened his prowess in innovation and practical problem-solving. Notably, his leadership and technical skills were spotlighted when he led his team to a third-place victory at the Google x MIT hackathon in 2023.
Our Select Advisors
Connecting You to Cutting-Edge Medical Research Opportunities
Friedrich Kursten
Clinical Operations and Technical Advisor
Friedrich is a true veteran in the clinical trials industry. With decades of experience in CROs and as a former Senior Vice President of Clinical Operations at OctaPharma, he has overseen numerous successful clinical development programs. His operational knowledge and hands-on approach is invaluable to us.
Dr. Ulrich Thibaut
Business Strategy Advisor
With over 25 years in the pharmaceutical and biotech industries, Ulrich has held several high-level positions, including Member of the Supervisory Board at Glycotope GmbH and Member of the Board R&D at Octapharma. He shares his deep expertise in research and strategic leadership to help us deliver the best value to our partners.
Dominic Jud
Regulatory and Compliance Advisor
With over 10 years of experience in regulatory affairs, Dominic has led global regulatory strategies at Novo Nordisk. As Global Regulatory Lead for a blockbuster obesity drug, he excels in managing regulatory submissions and health authority interactions. His expertise in developing and implementing RA strategies and leading regulatory teams is crucial for navigating regulatory challenges and ensuring compliance in clinical trials.
Christoph Heubeck
Financial and Business Strategy Advisor
With over 20 years of experience in strategy and business development, Chris has held several key roles, including Head of P&C Strategic Transformation at UBS, Senior Business Strategist at Boston Consulting Group (BCG), and Manager at KPMG Switzerland. His expertise in corporate strategy, digital transformation, and cross-functional coordination makes his advice instrumental in shaping our business strategies and achieving operational excellence.
Submit a Request
We will get in touch with you, to provide you with all necessary information.
